Sand Grove Capital Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-129,557
Closed -$3.87M 20
2025
Q3
$3.87M Buy
+129,557
New +$4.32M 1.89% 10
2024
Q3
Sell
-355,317
Closed -$14.9M 19
2024
Q2
$14.9M Buy
+355,317
New +$12.1M 4.37% 7

Other funds holding SRDX

Sand Grove Capital Management's SRDX Position: Q4 2025 in Review

Sand Grove Capital Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 129,557 shares — an estimated $3.87M sold.

Sand Grove Capital Management first reported a position in SRDX in Q2 2024 and held it in 2 quarters. The position peaked at $14.9M in Q2 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • Sand Grove Capital Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • Sand Grove Capital Management sold 129,557 Surmodics shares in Q4 2025, an estimated $3.87M.
  • Sand Grove Capital Management first reported a position in Surmodics in Q2 2024 and held it in 2 quarters.
  • Sand Grove Capital Management's Surmodics position peaked at $14.9M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Sand Grove Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.